Informazioni sul prodotto
- Cannabidiol hydroxyquinone (CBDHQ)
- 2,5-Cyclohexadiene-1,4-dione
- 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-
- 2,5-Cyclohexadiene-1,4-dione
- 3-hydroxy-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-
- (1R-trans)-
- 3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione
- HU 331
- VCE 004
- (3S,4R)-3-Hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl-3,4-p-benzoquinone
- Vedi altri sinonimi
- (6'R)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-1,1'-bi(cyclohexane)-2',3,6-triene-2,5-dione
- 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-
- 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-
- Hu-331
- Vce 004
Stability Light Sensitive
Applications A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than Doxorubicin and thus it has a high potential for development as a new anticancer drug.
References Dana, B., et al.: J. Clin. Oncol., 11, 644 (1993), Feleszko, W., et al.: Clin. Cancer Res., 6, 2044 (2000), Kogan, N., et al.: J. Med. Chem., 47, 3800 (2004),
Proprietà chimiche
Richiesta tecnica su: TR-C175315 Cannabidiol Hydroxyquinone
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.